Pierre Pradat

Hospices Civils de Lyon

Papers

1

Total Citations

48

H-Index

1

About

Pierre Pradat is a leading figure in head and neck surgical oncology, with a primary focus on transoral robotic surgery (TORS) for the treatment of supraglottic squamous cell carcinoma. His major contribution lies in pioneering and validating TORS as a minimally invasive alternative to traditional open surgery for supraglottic laryngectomy. Through his work with the French Robotic Surgery Group of GETTEC, Pradat conducted a landmark multicenter observational study that established the oncologic safety and efficacy of this approach, reporting favorable outcomes that have helped shift clinical practice toward less morbid surgical techniques. His most cited paper (48 citations) provides critical evidence on survival and local control rates, directly influencing treatment guidelines for early and select advanced supraglottic cancers. By demonstrating that TORS can achieve comparable oncologic results with reduced recovery times and better functional preservation, Pradat has improved the quality of life for countless patients. His research continues to shape the adoption of robotic surgery in head and neck oncology, cementing his reputation as a key innovator in the field.

Research Focus

Key Achievements

1
H-Index
1
Papers
48
Total Citations
48
Avg Citations/Paper
🏆 Most Cited Paper
Oncologic outcomes with transoral robotic surgery for supraglottic squamous cell carcinoma: Results of the French Robotic Surgery Group of GETTEC
48 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 10
🏛 Institutions: Hospices Civils de Lyon

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago